M. Rinaldini

863 total citations
9 papers, 664 citations indexed

About

M. Rinaldini is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Rinaldini has authored 9 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Rinaldini's work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Estrogen and related hormone effects (3 papers). M. Rinaldini is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Estrogen and related hormone effects (3 papers). M. Rinaldini collaborates with scholars based in Italy and Netherlands. M. Rinaldini's co-authors include A. Rubagotti, M. Mesiti, Francesco Boccardo, V. Distante, Pamela Guglielmini, Mauro Porpiglia, P Sismondi, Franco Buzzi, Roberto Franchi and B. Massidda and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M. Rinaldini

9 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Rinaldini Italy	6	501	406	401	130	60	9	664
A. Fini Italy	6	450 0.9×	334 0.8×	352 0.9×	99 0.8×	49 0.8×	9	585
G. Gademann Germany	5	517 1.0×	442 1.1×	395 1.0×	129 1.0×	61 1.0×	14	733
Joern Hilfrich Germany	5	491 1.0×	463 1.1×	407 1.0×	119 0.9×	63 1.1×	11	731
Jan Smeets Netherlands	7	282 0.6×	261 0.6×	218 0.5×	110 0.8×	47 0.8×	8	421
D Romeo Italy	4	440 0.9×	331 0.8×	365 0.9×	87 0.7×	41 0.7×	7	545
Roberto Travaglini Italy	6	333 0.7×	245 0.6×	222 0.6×	47 0.4×	61 1.0×	8	509
G Gucciardo Italy	7	282 0.6×	248 0.6×	230 0.6×	48 0.4×	94 1.6×	12	550
Mikael von Euler Sweden	6	337 0.7×	255 0.6×	257 0.6×	137 1.1×	108 1.8×	12	531
T Tjabbes Netherlands	6	408 0.8×	289 0.7×	291 0.7×	142 1.1×	68 1.1×	12	617
Lars Erik Krag Norway	8	294 0.6×	309 0.8×	184 0.5×	43 0.3×	58 1.0×	8	509

Countries citing papers authored by M. Rinaldini

Since Specialization

Citations

This map shows the geographic impact of M. Rinaldini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rinaldini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rinaldini more than expected).

Fields of papers citing papers by M. Rinaldini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rinaldini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rinaldini. The network helps show where M. Rinaldini may publish in the future.

Co-authorship network of co-authors of M. Rinaldini

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rinaldini. A scholar is included among the top collaborators of M. Rinaldini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rinaldini. M. Rinaldini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Boccardo, Francesco, A. Rubagotti, Pamela Guglielmini, et al.. (2006). Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Annals of Oncology. 17(7). vii10–vii14. 158 indexed citations

Boccardo, Francesco, A. Rubagotti, Matteo Puntoni, et al.. (2005). Switching to anastrozole (ANA) vs continued tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian tamoxifen anastrozole (ITA) trial. Journal of Clinical Oncology. 23(16_suppl). 526–526. 89 indexed citations

Boccardo, Francesco, A. Rubagotti, Matteo Puntoni, et al.. (2005). Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen Anastrozole Trial. Journal of Clinical Oncology. 23(22). 5138–5147. 342 indexed citations

Ballestrero, Alberto, A. Rubagotti, Fabio Ferrando, et al.. (2001). Adjuvant Chemotherapy with High-Dose Cyclophosphamide, Etoposide and Cisplatin Intensification without Progenitor Cell Support in Breast Cancer Patients with Ten or More Involved Nodes: 5-Year Results of a Pilot Trial. Oncology. 60(3). 221–227. 2 indexed citations

Pacini, P, M. Rinaldini, R Algeri, et al.. (2000). FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results. European Journal of Cancer. 36(8). 966–975. 30 indexed citations

Tucci, Enrico, et al.. (1998). Carboplatin and Vinorelbine in the Treatment of Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 21(1). 67–71. 26 indexed citations

Amoroso, D., Francesco Boccardo, A. Rubagotti, et al.. (1997). 0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes (N ≥ 10): preliminary results of an Italian breast cancer adjuvant study group (GROCTA) trial. The Breast. 6(4). 232–232. 1 indexed citations

Pacini, P, Enrico Tucci, R Algeri, et al.. (1994). Combination chemotherapy with epirubicin and mitomycin C as first-line treatment in advanced breast cancer. European Journal of Cancer. 30(4). 460–463. 3 indexed citations

Neri, B, et al.. (1993). Conventional Versus High-Dose Epidoxorubicin as Single Agent in Advanced Breast Cancer. Cancer Investigation. 11(2). 106–112. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact